世界の生体材料市場(~2025年):材料別(金属、セラミック、ポリマー、天然)、用途別(心臓血管、整形外科、歯科、形成外科、創傷治癒、神経障害、組織工学、眼科)

◆英語タイトル:Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2025
◆商品コード:BT-1556
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年1月18日
◆ページ数:299
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は世界の生体材料市場規模が2020年355億ドルから2025年475億ドルまで、年平均6.0%成長すると予測しています。本調査レポートでは、生体材料の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、規制評価、種類別(金属、重合体、セラミック、天然)分析、用途別(心臓血管、整形外科、眼科、歯科、形成外科、創傷治癒、組織工学、神経障害・中枢神経系、その他)分析、地域別分析、競争状況、企業情報、隣接/関連市場を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・規制評価
・生体材料の世界市場規模:種類別(金属、重合体、セラミック、天然)
・生体材料の世界市場規模:用途別(心臓血管、整形外科、眼科、歯科、形成外科、創傷治癒、組織工学、神経障害・中枢神経系、その他)
・生体材料の世界市場規模:地域別
・競争状況
・企業情報
・隣接/関連市場
【レポートの概要】

“The global biomaterials market is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.”
Growth in this market is primarily attributed to increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidences of cardiovascular diseases, and rising awareness and research on regenerative medicine.

“By metallic biomaterials segment, the Titanium & Titanium Alloys segment accounted for the fastest-growing segment of thebiomaterials market.”
On the basis of type, the metallic biomaterials are further segmented as Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, and Magnesium. TheTitanium & Titanium Alloys accounted for the fastest-growing segment of the metallic biomaterials segment. sThese biomaterials do not show any form of toxicity or allergic reactions on contact with the body. Additionally, factors such as excellent biocompatibility, corrosion resistance, the balance of mechanical properties, and low weight stimulate the demand for titanium-based biomaterials.

“By Cardiovascular application segment, stents Catheters accounted for the largest share of the biomaterials market”
Based on application, the cardiovascular application market is categorized into nine sub-segments— Catheters, Stents, Implantable Cardiac Defibrillators, Pacemakers, Sensors, Heart Valves, Vascular Grafts, Guidewires, and Other products. Catheters accounted for the largest share of the cardiovascular application segment due to the shift in patient preference from traditional open surgeries to minimally invasive surgeries. This trend is expected to propel the use of catheters and in turn, drive the growth of the biomaterials market during the forecast period.

“Asia Pacific: The fastest-growing region in the biomaterials market.”
The Asia Pacific region is estimated to grow at the highest CAGR in the biomaterials market during the forecast period, this is mainly due to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.

“North America: the largest share of the biomaterials market”
North America accounted for the largest share of the biomaterials market. Factors such as rising biomaterials-based research, growing demand for plastic surgeries, increase in cancer incidence, and the growing number of cardiovascular diseases are contributing to the growth of the biomaterials market in the US. In Canada, market growth is mainly driven by increasing funding for biomaterials and increasing R&D activity.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Company– Tier 1 – 37%, Tier 2- 22%, Tier 3- 41%
• By Designation— C Level – 25%, Directors – 20%, Others – 55%
• By Region— North America – 40%, Europe – 27%, APAC – 20%, RoW- 13%

The biomaterials market is dominated by a few globally established players such as BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (Germany),Carpenter Technology (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Mitsubishi Chemical Holdings Corporation (Japan), Victrex Plc (UK), Berkeley Advanced Biomaterials (US), GELITA AG (Germany), Zeus Industrial Products, Inc. (US), Cam Bioceramics (Netherlands), Solvay (US), AB Specialty Silicones (US), CoorsTek (US), CeramTec GmbH (Germany), The Lubrizol Corporation (US), Olympus Terumo Biomaterials Corporation (Japan), Xylos Corporation (US), Noble Biomaterials, Inc. (US), Dimension Inx (US), Artoss, Inc. (US), RDI Group (US), and Riton Biomaterial Co., Ltd. (China).

Research Coverage:
The report segments the biomaterialsmarket based on region (Asia Pacific, Europe, North America, and RoW), by type (Metallic Biomaterials [Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium])(Ceramic Biomaterials [Calcium Phosphate, Zirconia, Aluminium Oxide, Calcium Sulphate, Carbon, Glass])(Polymeric Biomaterials [Polymethylmethacrylate (PMMA), Polyethylene, Polyester, Polyvinlychloride (PVC), Silicone Rubber, Nylon, PEEK, Other Polymers]). (Natural Biomaterials [Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin, Alginates, Silk]).By application (Cardiovascular [Stents, Pacemakers, Implantable Cardiac Defibrillators, Heart Valves, Catheters, Vascular, Grafts, Guidewires, Sensors, Others]), (Orthopedic [Joint Replacement {Knee Replacement, Hip Replacement, Shoulder Replacements, Others}]), (Viscosupplementation), (Bioresorbabale Tissue Fixation Products [Suture Anchors, Interference Screws, Meniscal Repair Tacks, Meshes]), (Spine [Spinal Fusion], [Motion Preservation/Dynamic Stabilization {Pedicle-based rod Systems, Interspinous Spacers, Artificial Discs}], [Minimally Invasive Fusion Surgery], [Synthetic bone grafts], [Fracture fixation devices {Bone Plates, Screws, Pins, Rods, Wires}], (Ophthalmology [Intraocular Lens, Contact Lens, Functional Replacements of Ocular Tissues, Synthetic Corneas, Others]), (Dental [Dental Implants, Dental Bone Grafts & Substitutes, Dental Membranes, Tissue Regeneration Materials]), (Plastic Surgery [Soft Tissue Fillers, Craniofacial Surgery]), (Wound Healing [Wound Closure Devices {Sutures, Staples}], [Surgical Hemostats], [Internal Tissue Sealant], [Adhesion Barriers], [Hernia Meshes]), Tissue Engineering [Scaffolds For Regenerative Medicine, Nanomaterials For Biosensing Applications, Tailoring of Inorganic Nanoparticles], Neurology [Shunting Systems, Cortical Neural Prosthetics (CNP), Hydrogel Scaffolds for CNS Repair, Neural Stem Cell Encapsulation], (Other Applications [Drug Delivery Systems, Gastrointestinal Applications, Bariatric Surgery, Urinary Applications]). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges and trends in the biomaterials market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biomaterials market and provides them information on key market drivers, restraints, challenges, opportunities and trends.

【レポートの目次】

1 INTRODUCTION 31
1.1 OBJECTIVES OF STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
FIGURE 3 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 39
FIGURE 6 MARKET SIZE ESTIMATION: BIOMATERIALS MARKET 40
FIGURE 7 SEGMENTAL ASSESSMENT: BIOMATERIALS MARKET 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS FOR THE STUDY 43
3 EXECUTIVE SUMMARY 44
FIGURE 9 BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 44
FIGURE 10 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 45
FIGURE 11 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 45
FIGURE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 46
FIGURE 13 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 47
FIGURE 14 CARDIOVASCULAR APPLICATIONS DOMINATED THE BIOMATERIALS MARKET IN 2019 48
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE BIOMATERIALS MARKET 49
4 PREMIUM INSIGHTS 50
4.1 BIOMATERIALS MARKET OVERVIEW 50
FIGURE 16 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET 50
4.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE & COUNTRY (2019) 51
FIGURE 17 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN BIOMATERIALS MARKET IN 2019 51
4.3 METALLIC BIOMATERIALS MARKET, BY TYPE 52
FIGURE 18 TITANIUM & TITANIUM ALLOYS ARE PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 19 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 53
5.2.1 DRIVERS 54
5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials 54
5.2.1.2 Increasing demand for implantable devices 54
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications 55
5.2.1.4 Rising incidence of cardiovascular diseases 55
5.2.1.5 Increasing research on regenerative medicine 56
5.2.2 RESTRAINTS 57
5.2.2.1 Stringent clinical & regulatory processes 57
5.2.2.2 Unfavorable healthcare reforms in the US 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growing healthcare market in emerging economies 57
5.2.3.2 Increasing number of free-trade agreements 58
5.2.4 CHALLENGES 59
5.2.4.1 Limitations of biomaterial-based products 59
5.2.4.2 Shortage of skilled surgeons 59
5.2.5 TRENDS 59
5.2.5.1 Impact of COVID-19 on the biomaterials market 59

6 REGULATORY ASSESSMENT 61
6.1 INTRODUCTION 61
6.2 US 61
6.2.1 INTRODUCTION 61
6.2.2 FDA DEVICE CLASSIFICATION 62
FIGURE 20 US: REGULATORY APPROVAL PROCESS 63
6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT 64
FIGURE 21 REGULATORY APPROVAL TIMELINE IN THE US 64
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS 65
6.3 CANADA 65
6.3.1 INTRODUCTION 65
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS 66
6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT 67
FIGURE 23 REGULATORY APPROVAL TIMELINE IN CANADA 67
6.3.3 HEALTH CANADA CLASSIFICATION 67
6.4 EUROPE 68
6.4.1 INTRODUCTION 68
6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION 68
FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS 69
6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT 70
FIGURE 25 REGULATORY APPROVAL TIMELINE IN EUROPE 70
6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE 70
6.5 JAPAN 71
6.5.1 INTRODUCTION 71
6.5.2 PMDA DEVICE CLASSIFICATION 71
FIGURE 26 JAPAN: REGULATORY APPROVAL PROCESS 72
6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT 73
FIGURE 27 REGULATORY APPROVAL TIMELINE IN JAPAN 73
6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN 73
6.6 CHINA 74
6.6.1 INTRODUCTION 74
6.6.2 CFDA DEVICE CLASSIFICATION 75
FIGURE 28 CHINA: REGULATORY APPROVAL PROCESS 75
6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT 76
FIGURE 29 REGULATORY APPROVAL TIMELINE IN CHINA 76
6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA 76
6.7 INDIA 77
6.7.1 INTRODUCTION 77
FIGURE 30 INDIA: REGULATORY APPROVAL PROCESS 77
6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION 78

6.8 AUSTRALIA 78
6.8.1 INTRODUCTION 78
6.8.2 TGA DEVICE CLASSIFICATION 79
FIGURE 31 AUSTRALIA: REGULATORY APPROVAL PROCESS 80
6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 81
FIGURE 32 REGULATORY APPROVAL TIMELINE IN AUSTRALIA 81
7 BIOMATERIALS MARKET, BY TYPE 82
7.1 INTRODUCTION 83
TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 83
TABLE 2 BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 83
TABLE 3 BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 84
7.2 METALLIC BIOMATERIALS 84
TABLE 4 METALLIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 84
TABLE 5 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 85
TABLE 6 METALLIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 85
TABLE 7 METALLIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 85
7.2.1 STAINLESS STEEL 86
7.2.1.1 Stainless steel dominates the metallic biomaterials market 86
TABLE 8 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 86
TABLE 9 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 86
7.2.2 TITANIUM & TITANIUM ALLOYS 87
7.2.2.1 Growing number of joint replacement procedures will drive the market for titanium biomaterials 87
TABLE 10 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 87
TABLE 11 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 87
7.2.3 COBALT-CHROME ALLOYS 88
7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys 88
TABLE 12 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 88
TABLE 13 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 88
7.2.4 GOLD 89
7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials 89
TABLE 14 GOLD BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 89
TABLE 15 GOLD BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 89
7.2.5 SILVER 90
7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products 90
TABLE 16 SILVER BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 90
TABLE 17 SILVER BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 90
7.2.6 MAGNESIUM 91
7.2.6.1 Biodegradable characteristic of magnesium stimulates the growth of this market segment 91
TABLE 18 MAGNESIUM BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 91
TABLE 19 MAGNESIUM BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 91
7.3 POLYMERIC BIOMATERIALS 92
TABLE 20 APPLICATIONS OF SYNTHETIC POLYMERS 92
TABLE 21 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 93
TABLE 22 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 93
TABLE 23 POLYMERIC BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 93
TABLE 24 POLYMERIC BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 94
7.3.1 POLYMETHYLMETHACRYLATE (PMMA) 94
7.3.1.1 PMMA dominates the polymeric biomaterials market 94
TABLE 25 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 94
TABLE 26 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 95
7.3.2 POLYETHYLENE 95
7.3.2.1 Wear and tear resistance of polyethylene has made it popular in hip and knee joint replacements 95
TABLE 27 POLYETHYLENE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 95
TABLE 28 POLYETHYLENE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 96
7.3.3 POLYESTER 96
7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications 96
TABLE 29 POLYESTER BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 96
TABLE 30 POLYESTER BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 97
7.3.4 POLYVINYLCHLORIDE 97
7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth 97
TABLE 31 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 97
TABLE 32 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 97
7.3.5 SILICONE RUBBER 98
7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures 98
TABLE 33 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 98
TABLE 34 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 98
7.3.6 NYLON 99
7.3.6.1 Low weight, corrosion resistance, and wide applications of nylon are expected to drive the market demand 99
TABLE 35 NYLON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 99
TABLE 36 NYLON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 99
7.3.7 POLYETHERETHERKETONE 100
7.3.7.1 PEEK is gaining popularity as a viable alternative to metals 100
TABLE 37 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 38 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 100
7.3.8 OTHER POLYMERIC BIOMATERIALS 101
TABLE 39 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 40 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 101
7.4 CERAMIC BIOMATERIALS 102
TABLE 41 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 102
TABLE 42 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 102
TABLE 43 CERAMIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 103
TABLE 44 CERAMIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 103
7.4.1 CALCIUM PHOSPHATE 103
7.4.1.1 Calcium phosphate is the largest segment in the ceramic biomaterials market 103
TABLE 45 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 104
TABLE 46 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 104
7.4.2 ZIRCONIA 104
7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth 104
TABLE 47 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 105
TABLE 48 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 105
7.4.3 ALUMINUM OXIDE 105
7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market 105
TABLE 49 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 50 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 106
7.4.4 CALCIUM SULFATE 106
7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use 106
TABLE 51 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 106
TABLE 52 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 107
7.4.5 CARBON 107
7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth 107
TABLE 53 CARBON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 107
TABLE 54 CARBON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 108
7.4.6 GLASS 108
7.4.6.1 Rising number of orthopedic and dental procedures is likely to drive the demand for glass biomaterials 108
TABLE 55 GLASS BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 56 GLASS BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 108
7.5 NATURAL BIOMATERIALS 109
TABLE 57 APPLICATIONS OF NATURAL BIOMATERIALS 109
TABLE 58 NATURAL BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 110
TABLE 59 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 110
TABLE 60 NATURAL BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 110
TABLE 61 NATURAL BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 111
7.5.1 HYALURONIC ACID 111
7.5.1.1 Rising prevalence of osteoarthritis to drive the hyaluronic acid market 111
TABLE 62 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 63 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 111
7.5.2 COLLAGEN 112
7.5.2.1 Rising prevalence of target applications to drive growth in the collagen market 112
TABLE 64 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 112
TABLE 65 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 112
7.5.3 GELATIN 113
7.5.3.1 Low cost of gelatin to drive its market growth 113
TABLE 66 GELATIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 113
TABLE 67 GELATIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 113
7.5.4 FIBRIN 114
7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding 114
TABLE 68 FIBRIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 114
TABLE 69 FIBRIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 114
7.5.5 CELLULOSE 115
7.5.5.1 Cellulose finds applications in wound healing, skin regeneration,
and ophthalmology 115
TABLE 70 CELLULOSE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 115
TABLE 71 CELLULOSE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 115
7.5.6 CHITIN 116
7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility 116
TABLE 72 CHITIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 116
TABLE 73 CHITIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 116
7.5.7 ALGINATES 117
7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery 117
TABLE 74 ALGINATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 75 ALGINATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 117
7.5.8 SILK 118
7.5.8.1 Flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications 118
TABLE 76 SILK BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 77 SILK BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 118
8 BIOMATERIALS MARKET, BY APPLICATION 119
8.1 INTRODUCTION 120
TABLE 78 BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 120
TABLE 79 BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 120
8.2 CARDIOVASCULAR 121
TABLE 80 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY PRODUCT, 2016–2019 (USD MILLION) 121
TABLE 81 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY PRODUCT, 2020–2025 (USD MILLION) 122
TABLE 82 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 122
TABLE 83 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 122
8.2.1 CATHETERS 123
8.2.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive the catheters market 123
TABLE 84 BIOMATERIALS MARKET FOR CATHETERS, BY REGION,
2016–2019 (USD MILLION) 123
TABLE 85 BIOMATERIALS MARKET FOR CATHETERS, BY REGION,
2020–2025 (USD MILLION) 123
8.2.2 STENTS 124
8.2.2.1 Increasing number of coronary intervention procedures to boost the demand for implantable stents 124
TABLE 86 BIOMATERIALS MARKET FOR STENTS, BY REGION,
2016–2019 (USD MILLION) 124
TABLE 87 BIOMATERIALS MARKET FOR STENTS, BY REGION,
2020–2025 (USD MILLION) 124
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 125
8.2.3.1 Growing geriatric population is expected to increase the demand for implantable cardiac defibrillators 125
TABLE 88 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS,
BY REGION, 2016–2019 (USD MILLION) 125
TABLE 89 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS,
BY REGION, 2020–2025 (USD MILLION) 125
8.2.4 PACEMAKERS 126
8.2.4.1 High prevalence of bradycardia is increasing the demand for pacemakers 126
TABLE 90 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION,
2016–2019 (USD MILLION) 126
TABLE 91 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION,
2020–2025 (USD MILLION) 126
8.2.5 SENSORS 127
8.2.5.1 Increasing prevalence of cardiac disorders is boosting the demand for cardiovascular sensors 127
TABLE 92 BIOMATERIALS MARKET FOR SENSORS, BY REGION,
2016–2019 (USD MILLION) 127
TABLE 93 BIOMATERIALS MARKET FOR SENSORS, BY REGION,
2020–2025 (USD MILLION) 127
8.2.6 HEART VALVES 128
8.2.6.1 Growing geriatric population is set to increase the demand for prosthetic valves 128
TABLE 94 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 128
TABLE 95 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION,
2016–2019 (USD MILLION) 128
TABLE 96 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION,
2020–2025 (USD MILLION) 129
8.2.7 VASCULAR GRAFTS 129
8.2.7.1 Various research studies related to the use of biomaterials in vascular grafts will open opportunities for growth of the market 129
TABLE 97 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION,
2016–2019 (USD MILLION) 129
TABLE 98 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION,
2020–2025 (USD MILLION) 130
8.2.8 GUIDEWIRES 130
8.2.8.1 Guidewires are widely used for guiding catheters and placing stents inside the heart 130
TABLE 99 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION,
2016–2019 (USD MILLION) 130
TABLE 100 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION,
2020–2025 (USD MILLION) 130
8.2.9 OTHER PRODUCTS 131
TABLE 101 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION,
2016–2019 (USD MILLION) 131
TABLE 102 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION,
2020–2025 (USD MILLION) 131

8.3 ORTHOPEDIC 132
TABLE 103 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2016–2019 (USD MILLION) 132
TABLE 104 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2020–2025 (USD MILLION) 133
TABLE 105 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 133
TABLE 106 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 133
8.3.1 JOINT REPLACEMENT 134
TABLE 107 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2016–2019 (USD MILLION) 134
TABLE 108 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2020–2025 (USD MILLION) 134
TABLE 109 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 135
TABLE 110 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 135
8.3.1.1 Knee replacement 136
8.3.1.1.1 Increasing number of knee replacement procedures across the globe to drive market growth 136
TABLE 111 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 136
TABLE 112 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 136
8.3.1.2 Hip replacement 137
8.3.1.2.1 Hip and knee joint replacements are the most commonly performed procedures in the US—a key factor driving growth 137
TABLE 113 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 137
TABLE 114 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 137
8.3.1.3 Shoulder replacement 138
8.3.1.3.1 Shoulder replacement is the most common joint replacement surgery conducted globally 138
TABLE 115 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 138
TABLE 116 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 138
8.3.1.4 Other joint replacement applications 139
TABLE 117 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 139
TABLE 118 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 139
8.3.2 VISCOSUPPLEMENTATION 140
8.3.2.1 Rising cases of osteoarthritis will drive growth in the viscosupplementation market 140
TABLE 119 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 140
TABLE 120 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 141
8.3.3 BIORESORBABLE TISSUE FIXATION 141
TABLE 121 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 141
TABLE 122 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT,
2020–2025 (USD MILLION) 142
TABLE 123 BIORESORBABLE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 142
TABLE 124 BIORESORBABLE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 142
8.3.3.1 Suture anchors 143
8.3.3.1.1 Growing awareness about suture anchor devices will drive market growth 143
TABLE 125 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION,
2016–2019 (USD MILLION) 143
TABLE 126 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION,
2020–2025 (USD MILLION) 143
8.3.3.2 Interference screws 144
8.3.3.2.1 Increasing awareness about ACL will contribute to market growth 144
TABLE 127 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION,
2016–2019 (USD MILLION) 144
TABLE 128 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION,
2020–2025 (USD MILLION) 144
8.3.3.3 Meniscal repair tacks 145
8.3.3.3.1 Rising sports injuries will drive growth in the meniscal repair tacks market 145
TABLE 129 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION,
2016–2019 (USD MILLION) 145
TABLE 130 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION,
2020–2025 (USD MILLION) 145
8.3.3.4 Meshes 146
8.3.3.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants increase the demand for bioresorbable meshes 146
TABLE 131 BIOMATERIALS MARKET FOR MESHES, BY REGION,
2016–2019 (USD MILLION) 146
TABLE 132 BIOMATERIALS MARKET FOR MESHES, BY REGION,
2020–2025 (USD MILLION) 146
8.3.4 SPINE 147
TABLE 133 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2016–2019 (USD MILLION) 147
TABLE 134 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2020–2025 (USD MILLION) 147
TABLE 135 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2016–2019 (USD MILLION) 147
TABLE 136 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2020–2025 (USD MILLION) 148
8.3.4.1 Spinal fusion 148
8.3.4.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth 148
TABLE 137 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2016–2019 (USD MILLION) 148
TABLE 138 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2025 (USD MILLION) 149
8.3.4.2 Minimally invasive fusion 149
8.3.4.2.1 Advantages such as lesser pain post surgery and faster recovery to drive the demand for minimally invasive fusion procedures 149
TABLE 139 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES,
BY REGION, 2016–2019 (USD MILLION) 149
TABLE 140 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES,
BY REGION, 2020–2025 (USD MILLION) 150
8.3.4.3 Motion preservation & dynamic stabilization 150
TABLE 141 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2016–2019 (USD MILLION) 150
TABLE 142 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2020–2025 (USD MILLION) 151
TABLE 143 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2016–2019 (USD MILLION) 151
TABLE 144 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2020–2025 (USD MILLION) 151
8.3.4.3.1 Pedicle-based rod systems 152
8.3.4.3.1.1 Rising geriatric population will result in growth in the pedicle-based rod systems market 152
TABLE 145 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2016–2019 (USD MILLION) 152
TABLE 146 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2020–2025 (USD MILLION) 152
8.3.4.3.2 Interspinous spacers 153
8.3.4.3.2.1 High prevalence of degenerative spinal conditions will contribute to the growth of the interspinous spacers market 153
TABLE 147 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION,
2016–2019 (USD MILLION) 153
TABLE 148 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION,
2020–2025 (USD MILLION) 153
8.3.4.3.3 Artificial discs 154
8.3.4.3.3.1 High biocompatibility of biomaterials has led to their increased use in artificial discs 154
TABLE 149 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION,
2016–2019 (USD MILLION) 154
TABLE 150 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION,
2020–2025 (USD MILLION) 154
8.3.5 FRACTURE FIXATION DEVICES 155
TABLE 151 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE,
2016–2019 (USD MILLION) 155
TABLE 152 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE,
2020–2025 (USD MILLION) 155
TABLE 153 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2016–2019 (USD MILLION) 156
TABLE 154 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2020–2025 (USD MILLION) 156
8.3.5.1 Bone plates 157
8.3.5.1.1 Biomaterials form an integral component of bone plates due to their high biocompatibility 157
TABLE 155 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION,
2016–2019 (USD MILLION) 157
TABLE 156 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION,
2020–2025 (USD MILLION) 157
8.3.5.2 Screws 158
8.3.5.2.1 Screws made up of biomaterials such as stainless steel, titanium, and cobalt are extensively used in orthopedic procedures 158
TABLE 157 BIOMATERIALS MARKET FOR SCREWS, BY REGION,
2016–2019 (USD MILLION) 158
TABLE 158 BIOMATERIALS MARKET FOR SCREWS, BY REGION,
2020–2025 (USD MILLION) 158
8.3.5.3 Pins 159
8.3.5.3.1 Nonreactive metallic biomaterials such as stainless steel, titanium, and cobalt are majorly used to manufacture pins 159
TABLE 159 BIOMATERIALS MARKET FOR PINS, BY REGION, 2016–2019 (USD MILLION) 159
TABLE 160 BIOMATERIALS MARKET FOR PINS, BY REGION, 2020–2025 (USD MILLION) 159
8.3.5.4 Rods 160
8.3.5.4.1 Rods are preferred for fracture fixation procedures due to their high rigidity, easy mobility, and cost efficiency 160
TABLE 161 BIOMATERIALS MARKET FOR RODS, BY REGION, 2016–2019 (USD MILLION) 160
TABLE 162 BIOMATERIALS MARKET FOR RODS, BY REGION, 2020–2025 (USD MILLION) 160
8.3.5.5 Wires 161
8.3.5.5.1 Wires made up of metallic biomaterials are widely used to treat fractures of small bones 161
TABLE 163 BIOMATERIALS MARKET FOR WIRES, BY REGION,
2016–2019 (USD MILLION) 161
TABLE 164 BIOMATERIALS MARKET FOR WIRES, BY REGION,
2020–2025 (USD MILLION) 161
8.3.6 SYNTHETICS BONE GRAFTS 162
8.3.6.1 Growing geriatric population and increasing incidence of sports-related injuries are driving the market for synthetic bone grafts 162
TABLE 165 BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION,
2016–2019 (USD MILLION) 162
TABLE 166 BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION,
2020–2025 (USD MILLION) 162

8.4 OPHTHALMOLOGY 163
TABLE 167 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2016–2019 (USD MILLION) 163
TABLE 168 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION) 163
TABLE 169 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 164
TABLE 170 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 164
8.4.1 CONTACT LENSES 165
8.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive the market for contact lenses 165
TABLE 171 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION,
2016–2019 (USD MILLION) 165
TABLE 172 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION,
2020–2025 (USD MILLION) 165
8.4.2 INTRAOCULAR LENSES 166
8.4.2.1 Increasing prevalence of cataracts to drive the number of cataract surgeries performed 166
TABLE 173 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION,
2016–2019 (USD MILLION) 166
TABLE 174 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION,
2020–2025 (USD MILLION) 166
8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 167
8.4.3.1 Increasing funding and research activities for developing bionic eyes are driving the market for this application 167
TABLE 175 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2016–2019 (USD MILLION) 167
TABLE 176 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2020–2025 (USD MILLION) 167
8.4.4 SYNTHETIC CORNEAS 168
8.4.4.1 Growing number of corneal blindness cases worldwide to boost the demand for synthetic collagen biomaterials 168
TABLE 177 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION,
2016–2019 (USD MILLION) 168
TABLE 178 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION,
2020–2025 (USD MILLION) 168
8.4.5 OTHER OPHTHALMOLOGY APPLICATIONS 169
TABLE 179 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 169
TABLE 180 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS,
BY REGION, 2020–2025 (USD MILLION) 169
8.5 DENTAL 170
TABLE 181 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT,
2016–2019 (USD MILLION) 170
TABLE 182 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT,
2020–2025 (USD MILLION) 170
TABLE 183 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION,
2016–2019 (USD MILLION) 171
TABLE 184 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION,
2020–2025 (USD MILLION) 171
8.5.1 DENTAL IMPLANTS 171
8.5.1.1 Increasing awareness of dental services and improving quality of dental products are driving the growth of this market segment 171
TABLE 185 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES
IN THE US (2016) 172
TABLE 186 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION,
2016–2019 (USD MILLION) 172
TABLE 187 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION,
2020–2025 (USD MILLION) 172
8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 173
8.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth 173
TABLE 188 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES,
BY REGION, 2016–2019 (USD MILLION) 173
TABLE 189 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES,
BY REGION, 2020–2025 (USD MILLION) 173
8.5.3 DENTAL MEMBRANES 174
8.5.3.1 Dental membranes are widely used in oral and periodontal surgery to prevent unwanted infections in the oral cavity 174
TABLE 190 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION,
2016–2019 (USD MILLION) 174
TABLE 191 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION,
2020–2025 (USD MILLION) 174

8.5.4 TISSUE REGENERATION MATERIALS 175
8.5.4.1 Increasing prevalence of periodontal disease is driving the market for biomaterials in this particular application 175
TABLE 192 BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION,
2016–2019 (USD MILLION) 175
TABLE 193 BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION,
2020–2025 (USD MILLION) 175
8.6 PLASTIC SURGERY 176
TABLE 194 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION,
2016–2019 (USD MILLION) 176
TABLE 195 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION,
2020–2025 (USD MILLION) 176
TABLE 196 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION,
2016–2019 (USD MILLION) 176
TABLE 197 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION,
2020–2025 (USD MILLION) 177
8.6.1 SOFT-TISSUE FILLERS 177
8.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive the demand for soft-tissue fillers 177
TABLE 198 BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION,
2016–2019 (USD MILLION) 177
TABLE 199 BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION,
2020–2025 (USD MILLION) 178
8.6.2 CRANIOFACIAL SURGERY 178
8.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase the number of craniofacial surgeries 178
TABLE 200 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION,
2016–2019 (USD MILLION) 179
TABLE 201 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION,
2020–2025 (USD MILLION) 179
8.7 WOUND HEALING 179
TABLE 202 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2016–2019 (USD MILLION) 179
TABLE 203 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2020–2025 (USD MILLION) 180
TABLE 204 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 180
TABLE 205 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 180
8.7.1 WOUND CLOSURE DEVICES 181
TABLE 206 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2016–2019 (USD MILLION) 181
TABLE 207 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2020–2025 (USD MILLION) 181
TABLE 208 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2016–2019 (USD MILLION) 181
TABLE 209 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2020–2025 (USD MILLION) 182
8.7.1.1 Sutures 182
8.7.1.1.1 Sutures can be used as advanced biologically active components enabling the delivery of drugs 182
TABLE 210 BIOMATERIALS MARKET FOR SUTURES, BY REGION,
2016–2019 (USD MILLION) 182
TABLE 211 BIOMATERIALS MARKET FOR SUTURES, BY REGION,
2020–2025 (USD MILLION) 183
8.7.1.2 Staples 183
8.7.1.2.1 Staples are easy to place and can shorten the closure by 70–80% compared to sutures 183
TABLE 212 BIOMATERIALS MARKET FOR STAPLES, BY REGION,
2016–2019 (USD MILLION) 183
TABLE 213 BIOMATERIALS MARKET FOR STAPLES, BY REGION,
2020–2025 (USD MILLION) 184
8.7.2 SURGICAL HEMOSTATS 184
8.7.2.1 Surgical hemostats have the ability to control bleeding and reduce the need for frequent blood transfusions during surgical procedures 184
TABLE 214 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION,
2016–2019 (USD MILLION) 184
TABLE 215 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION,
2020–2025 (USD MILLION) 185
8.7.3 INTERNAL TISSUE SEALANTS 185
8.7.3.1 Internal tissue sealants are made of biomaterials such as fibrin, gelatin, thrombin, synthetic polymers, and biosynthetic polymers 185
TABLE 216 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2016–2019 (USD MILLION) 185
TABLE 217 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2020–2025 (USD MILLION) 186
8.7.4 ADHESION BARRIERS 186
8.7.4.1 Biomaterials such as Teflon sheets, animal membranes, gold foil, silk, and rubber are used as adhesion barriers 186
TABLE 218 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION,
2016–2019 (USD MILLION) 186
TABLE 219 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION,
2020–2025 (USD MILLION) 187
8.7.5 HERNIA MESHES 187
8.7.5.1 Meshes used in hernia repair are mainly made up of polymeric biomaterials 187
TABLE 220 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION,
2016–2019 (USD MILLION) 187
TABLE 221 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION,
2020–2025 (USD MILLION) 188
8.8 TISSUE ENGINEERING 188
TABLE 222 TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 188
TABLE 223 TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 189
TABLE 224 TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 189
TABLE 225 TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 189
8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE 190
8.8.1.1 Rise in organ transplantation procedures to drive the market 190
TABLE 226 TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2016–2019 (USD MILLION) 190
TABLE 227 TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2020–2025 (USD MILLION) 190
8.8.2 NANOMATERIALS FOR BIOSENSING 191
8.8.2.1 Growth in this segment will be driven by rising research in the field of nanotechnology 191
TABLE 228 TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS
FOR BIOSENSING, BY REGION, 2016–2019 (USD MILLION) 191
TABLE 229 TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS
FOR BIOSENSING, BY REGION, 2020–2025 (USD MILLION) 191
8.8.3 TAILORING OF INORGANIC NANOPARTICLES 192
8.8.3.1 Growing demand for nanotechnological medical products will be a key factor in driving the growth of this market 192
TABLE 230 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2016–2019 (USD MILLION) 192
TABLE 231 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2020–2025 (USD MILLION) 192
8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS 193
TABLE 232 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY PRODUCT, 2016–2019 (USD MILLION) 193
TABLE 233 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY PRODUCT, 2020–2025 (USD MILLION) 193
TABLE 234 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 193
TABLE 235 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY REGION, 2020–2025 (USD MILLION) 194
8.9.1 SHUNTING SYSTEMS 194
8.9.1.1 Rising cases of hydrocephalus will boost the market growth 194
TABLE 236 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION,
2016–2019 (USD MILLION) 194
TABLE 237 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION,
2020–2025 (USD MILLION) 195
8.9.2 CORTICAL NEURAL PROSTHETICS 195
8.9.2.1 Polymer-coated CNPs are relatively new in the market and are mainly used to treat paralyzed patients 195
TABLE 238 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2016–2019 (USD MILLION) 195
TABLE 239 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2020–2025 (USD MILLION) 196
8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR 196
8.9.3.1 With increasing incidence of spinal cord surgeries, the demand for hydrogel scaffolds is expected to grow in the coming years 196
TABLE 240 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR,
BY REGION, 2016–2019 (USD MILLION) 196
TABLE 241 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR,
BY REGION, 2020–2025 (USD MILLION) 197
8.9.4 NEURAL STEM CELL ENCAPSULATION 197
8.9.4.1 Lack of substitutes for the treatment of neurotrauma is boosting the market growth 197
TABLE 242 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION,
BY REGION, 2016–2019 (USD MILLION) 197
TABLE 243 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION,
BY REGION, 2020–2025 (USD MILLION) 198
8.10 OTHER APPLICATIONS 198
TABLE 244 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE,
2016–2019 (USD MILLION) 198
TABLE 245 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE,
2020–2025 (USD MILLION) 198
TABLE 246 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION,
2016–2019 (USD MILLION) 199
TABLE 247 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION,
2020–2025 (USD MILLION) 199
8.10.1 DRUG DELIVERY SYSTEMS 200
TABLE 248 BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION,
2016–2019 (USD MILLION) 200
TABLE 249 BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION,
2020–2025 (USD MILLION) 200
8.10.2 GASTROINTESTINAL APPLICATIONS 201
TABLE 250 BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 201
TABLE 251 BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS,
BY REGION, 2020–2025 (USD MILLION) 201
8.10.3 BARIATRIC SURGERY 202
TABLE 252 BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION,
2016–2019 (USD MILLION) 202
TABLE 253 BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION,
2020–2025 (USD MILLION) 202
8.10.4 URINARY APPLICATIONS 203
TABLE 254 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION,
2016–2019 (USD MILLION) 203
TABLE 255 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION,
2020–2025 (USD MILLION) 203
9 BIOMATERIALS MARKET, BY REGION 204
9.1 INTRODUCTION 205
TABLE 256 BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 205
TABLE 257 BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 205
FIGURE 33 BIOMATERIALS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 206
9.2 NORTH AMERICA 207
FIGURE 34 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT 207
TABLE 258 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 208
TABLE 259 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 208
TABLE 260 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE,
2016–2019 (USD MILLION) 208
TABLE 261 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE,
2020–2025 (USD MILLION) 208
TABLE 262 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 209
TABLE 263 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 209
9.2.1 US 209
9.2.1.1 US dominates the North American biomaterials market 209
TABLE 264 US: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 211
TABLE 265 US: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 211
TABLE 266 US: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 211
TABLE 267 US: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 212

9.2.2 CANADA 212
9.2.2.1 Increasing incidence of cardiovascular diseases to drive market growth in Canada 212
TABLE 268 CANADA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 213
TABLE 269 CANADA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 213
TABLE 270 CANADA: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 213
TABLE 271 CANADA: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 214
9.3 EUROPE 214
TABLE 272 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 214
TABLE 273 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 215
TABLE 274 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 215
TABLE 275 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 215
TABLE 276 EUROPE: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 216
TABLE 277 EUROPE: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 216
9.3.1 GERMANY 216
9.3.1.1 Large medical device market to support the adoption of biomaterials in Germany 216
TABLE 278 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 217
TABLE 279 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 217
TABLE 280 GERMANY: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 218
TABLE 281 GERMANY: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 218
9.3.2 UK 219
9.3.2.1 Availability of funds and the increasing number of cardiovascular procedures to drive the biomaterials market in the UK 219
TABLE 282 UK: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 219
TABLE 283 UK: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 220
TABLE 284 UK: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 220
TABLE 285 UK: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 220
9.3.3 FRANCE 221
9.3.3.1 Rising aging population and associated diseases to drive the market in France 221
TABLE 286 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 221
TABLE 287 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 221
TABLE 288 FRANCE: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 222
TABLE 289 FRANCE: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 222
9.3.4 SPAIN 223
9.3.4.1 Increasing research activities on biomaterials to drive growth
in Spain 223
TABLE 290 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 223
TABLE 291 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 223
TABLE 292 SPAIN: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 224
TABLE 293 SPAIN: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 224
9.3.5 REST OF EUROPE (ROE) 225
TABLE 294 ROE: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 225
TABLE 295 ROE: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 225
TABLE 296 ROE: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 226
TABLE 297 ROE: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 226
9.4 ASIA PACIFIC 227
FIGURE 35 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT 227
TABLE 298 APAC: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 228
TABLE 299 APAC: BIOMATERIALS MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 228
TABLE 300 APAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 228
TABLE 301 APAC: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 229
TABLE 302 APAC: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 229
TABLE 303 APAC: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 229
9.4.1 JAPAN 230
9.4.1.1 Growing medical devices industry to drive market growth 230
TABLE 304 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 230
TABLE 305 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 231
TABLE 306 JAPAN: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 231
TABLE 307 JAPAN: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 231
9.4.2 CHINA 232
9.4.2.1 Lucrative medical devices industry in China to drive market growth 232
TABLE 308 CHINA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 232
TABLE 309 CHINA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 233
TABLE 310 CHINA: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 233
TABLE 311 CHINA: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 233
9.4.3 INDIA 234
9.4.3.1 Large population base and growing medical tourism in India to drive the growth of the biomaterials market 234
TABLE 312 INDIA: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 234
TABLE 313 INDIA: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 234
TABLE 314 INDIA: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 235
TABLE 315 INDIA: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 235
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 236
TABLE 316 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 236
TABLE 317 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 236
TABLE 318 ROAPAC: BIOMATERIALS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 237
TABLE 319 ROAPAC: BIOMATERIALS MARKET, BY APPLICATION,
2020–2025 (USD MILLION) 237
9.5 REST OF THE WORLD (ROW) 238
TABLE 320 ROW: BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 238
TABLE 321 ROW: BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 238
TABLE 322 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 239
TABLE 323 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 239
10 COMPETITIVE LANDSCAPE 240
10.1 OVERVIEW 240
10.2 MARKET RANKING ANALYSIS 240
FIGURE 36 COMPANY RANKING IN THE BIOMATERIALS MARKET, 2019 240
10.3 MARKET EVALUATION FRAMEWORK 241
TABLE 324 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES & EXPANSIONS—THE MAJOR STRATEGIES ADOPTED BY PLAYERS 241
10.4 COMPETITIVE SCENARIO 241
10.4.1 KEY PRODUCT LAUNCHES 241
10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 242
10.4.3 KEY ACQUISITIONS 243
10.4.4 KEY EXPANSIONS 243
11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 244
11.1 OVERVIEW 244
11.2 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX 244
11.2.1 STARS 244
11.2.2 EMERGING LEADERS 244
11.2.3 PERVASIVE PLAYERS 244
11.2.4 PARTICIPANTS 245
FIGURE 37 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX, 2019 245
11.3 COMPANY PROFILES 246
(Business overview, Products offered, Recent developments & MnM View)*
11.3.1 BASF SE 246
FIGURE 38 BASF: COMPANY SNAPSHOT 246
11.3.2 COVESTRO AG 248
FIGURE 39 COVESTRO: COMPANY SNAPSHOT 248
11.3.3 CELANESE CORPORATION 251
FIGURE 40 CELANESE CORPORATION: COMPANY SNAPSHOT 251
11.3.4 CARPENTER TECHNOLOGY CORPORATION 253
FIGURE 41 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT 253
11.3.5 ROYAL DSM 255
FIGURE 42 ROYAL DSM: COMPANY SNAPSHOT 255
11.3.6 CORBION 258
FIGURE 43 CORBION: COMPANY SNAPSHOT 258
11.3.7 EVONIK INDUSTRIES 260
FIGURE 44 EVONIK INDUSTRIES: COMPANY SNAPSHOT 260
11.3.8 VICTREX PLC 263
FIGURE 45 VICTREX PLC: COMPANY SNAPSHOT 263
11.3.9 CERAMTEC GMBH 265
FIGURE 46 CERAMTEC GMBH: COMPANY SNAPSHOT 265
11.3.10 MITSUBISHI CHEMICAL HOLDINGS CORPORATION (ADVANSOURCE BIOMATERIALS CORP.) 267
FIGURE 47 MITSUBISHI CHEMICAL HOLDINGS CORPORATION: COMPANY SNAPSHOT 267
11.3.11 COORSTEK INC. 269
11.3.12 BERKELEY ADVANCED BIOMATERIALS 270
11.3.13 CAM BIOCERAMICS B.V. 271
11.3.14 ZEUS INDUSTRIAL PRODUCTS, INC. 272
11.3.15 GELITA AG 273
11.3.16 RDI GROUP (COLLAGEN SOLUTIONS PLC) 274
11.3.17 RITON BIOMATERIAL CO., LTD. 275
11.3.18 ARTOSS, INC. 275
11.3.19 NOBEL BIOMATERIALS 276
11.3.20 DIMENSION INX 276
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12 ADJACENT/RELATED MARKETS 277
12.1 INTRODUCTION 277
12.2 LIMITATIONS 277
12.3 MEDICAL CERAMICS MARKET 277
12.3.1 MARKET DEFINITION 277
12.3.2 MARKET OVERVIEW 277
12.3.3 MEDICAL CERAMICS MARKET, BY REGION 278
TABLE 325 MEDICAL CERAMICS MARKET, BY REGION, 2018–2025 (USD MILLION) 278
12.3.3.1 North America 278
TABLE 326 NORTH AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 278
12.3.3.2 Europe 279
TABLE 327 EUROPE: MEDICAL CERAMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 279
12.3.3.3 Asia Pacific 279
TABLE 328 ASIA PACIFIC: MEDICAL CERAMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 279
12.3.3.4 Latin America 280
TABLE 329 LATIN AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 280
12.4 BONE CEMENT & GLUE MARKET 280
12.4.1 MARKET DEFINITION 280
12.4.2 MARKET OVERVIEW 280
12.4.3 BONE CEMENT & GLUE MARKET, BY REGION 281
TABLE 330 BONE CEMENT & GLUE MARKET, BY REGION, 2015–2022 (USD MILLION) 281
12.4.3.1 North America 281
TABLE 331 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 281
12.4.3.2 Europe 282
TABLE 332 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 282
12.4.3.3 Asia Pacific 282
TABLE 333 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 282
13 APPENDIX 283
13.1 DISCUSSION GUIDE 283
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 295
13.3 AVAILABLE CUSTOMIZATIONS 297
13.4 RELATED REPORTS 297
13.5 AUTHOR DETAILS 298

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の生体材料市場(~2025年):材料別(金属、セラミック、ポリマー、天然)、用途別(心臓血管、整形外科、歯科、形成外科、創傷治癒、神経障害、組織工学、眼科)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆